Bryan Johnson Shifted Immortals Health Program Focus

The wellness entrepreneur recently pivoted his anti-aging program toward personalized disease cures.

Updated on Oct. 6, 2026 in Wellness

Bold vector editorial illustration featuring a glass serum vial and a metallic DNA helix, symbolizing personalized disease-curing therapies. — Wellness entrepreneur Bryan Johnson has shifted the focus of his Immortals program to prioritize developing therapies for specific diseases over purely cosmetic anti-aging goals. AI Illustration. Upload story photo >

Live Poll

Do you trust aesthetic filters more than medical interventions for appearing younger?

Bryan Johnson, who maintains an ambitious goal of achieving immortality by 2039, has refocused his Immortals health program to prioritize curing diseases. The entrepreneur also revealed he was diagnosed with autoimmune gastritis in May 2026.

Why it matters

Johnson stated he redirected his efforts after contemplating the most significant contributions he could make on the eve of the arrival of superintelligence. He now emphasizes disease-curing therapies over purely cosmetic anti-aging results.

The Immortals program currently utilizes a broad protocol of nutrition, hormones, peptides, GLP-1s, stem cells, and organoids to target health metrics comparable to an 18-year-old. Paul Conyngham reported that a custom mRNA vaccine shrunk his dog's tumors by 75%.

The players

Bryan Johnson

He is an American entrepreneur and venture capitalist known for his high-budget health and longevity experiments.

Kate Tolo

She is a participant in the Immortals program whose health regimen involves tracking millions of data points.

Paul Conyngham

He is an engineer based in Sydney, Australia, who has explored experimental mRNA vaccine technology.

The details

Johnson recently noted that digital editing techniques like filters and lighting often produce more immediate anti-aging results than medical therapies. His program has also supported participants like Kate Tolo, who is managing endometriosis, adenomyosis, and PMOS through intensive data tracking.

February 2026: Johnson launched the Immortals health program.
May 2026: Johnson was diagnosed with autoimmune gastritis.
June 30, 2026: Johnson announced his autoimmune gastritis diagnosis.
July 21, 2026: Johnson claimed he cloned himself as a newborn.
2039: Johnson aims to achieve immortality.

Health Landscape

The transition of the Immortals health program reflects a broader trend in the longevity industry where high-net-worth individuals are shifting from vanity metrics toward rigorous, disease-curing medical innovation. This evolution mirrors a departure from strictly lifestyle-based aging interventions.

The shift highlights how personalized health data, such as tracking millions of cycle points, is being used to manage complex conditions like endometriosis. While these intensive protocols are currently specialized, they represent emerging methods for tracking individual physiological responses.

The takeaway

The move toward disease-curing tools signifies a more pragmatic approach to long-term health than traditional aesthetic anti-aging. Readers should prioritize data-driven, physician-led diagnostics over anecdotal protocols to manage their own chronic health conditions.